Cancer jab can eradicate entire tumours in patients, trial shows
A clinical trial showed that a new cancer treatment, amivantamab, completely eliminated tumors in 15 out of 102 patients with head and neck cancer who had not responded to other therapies. The drug also significantly reduced tumor size in more than a third of participants, offering hope for patients with limited treatment options. The results, presented at a major cancer conference, suggest the treatment may be effective for other cancers as well.
A new cancer treatment called amivantamab has shown the ability to completely eliminate tumours in some patients who had previously failed other treatments.
This development offers new hope for patients with advanced cancers that have become resistant to standard therapies, potentially expanding treatment options.
The story highlights a promising medical breakthrough that could improve patient outcomes and underscores the importance of ongoing cancer research.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.